Why Most Peptide COAs Are Worthless (And the 3 Suppliers That Aren't)

Most Certificates of Analysis in the research peptide industry are decorative, not informative. They exist to make a product page look serious, not to tell a buyer what is actually in the vial.

Of the eight suppliers we evaluated in our 2026 Annual Purity Report, five shipped Certificates of Analysis with problems serious enough to make the documents effectively useless. The COA arrived. It looked technical. It had a percentage on it. And it told a buyer absolutely nothing verifiable about the specific bottle in the box.

This is the companion piece to our how to read a peptide COA guide. That article explained what a real COA contains. This one explains why most of what you see in this market doesn't qualify — and names the three suppliers in our 2026 evaluation whose documentation actually does.

For research use only. None of this is medical advice.

The state of peptide COAs in 2026

A Certificate of Analysis is supposed to be the single document that ties a specific physical vial to a specific analytical result. In a regulated pharmaceutical supply chain, a COA without batch-matching, current dates, raw chromatographic data, and an analyst's name would not pass quality assurance review at any serious facility.

In the research peptide market, that is the documentation standard you get from a small minority of suppliers. The majority publish something that looks like a COA at a distance and falls apart on inspection. Generic batch numbers. Test dates from 2022. Identical 99.9% purity numbers across every product they sell. Anonymous "analyst" signatures that resolve to a Photoshop layer.

We collected COAs from eight suppliers during our 2026 evaluation window. Five of those documents failed at least one of the basic verification tests below. Three did not. This article walks through both groups.

The 6 ways a peptide COA can be worthless

Each of these is a failure mode we observed in real documents from real suppliers in 2026. Any one of them is enough on its own to make the COA non-verifiable. Several of the suppliers we looked at managed to combine multiple failures in the same document.

1. Generic batch number that doesn't match the vial

This is the single most common failure mode. The supplier produced one COA at some point for some batch. They now attach that same PDF to every order, regardless of which batch the customer actually received.

The tell is simple. Read the batch or lot number on the vial label. Read the batch or lot number on the COA. If they don't match — or if the COA doesn't list a batch number at all and just shows a generic "Product: BPC-157" header — the document is not certifying the bottle in your hand. It is certifying some other bottle that may or may not have ever existed.

Three of the eight suppliers in our 2026 evaluation sent COAs whose batch identifiers did not match the vials shipped. One sent a COA with no batch field at all.

2. Outdated — tested 18+ months ago

Peptides degrade. A purity number from a synthesis batch tested two years ago tells you nothing about the bottle that arrived at your door this month. Even if the COA is otherwise legitimate, the test date has to be recent enough that the analytical result still describes the current product.

Our threshold: a COA test date within the last 12 months, ideally within the last 90 days for compounds known to be temperature- or moisture-sensitive. Anything older is a synthesis record, not a current quality document.

One supplier in our 2026 evaluation provided a COA dated October 2022 for a batch shipped in March 2026. The supplier framed this as evidence the product had been tested. In practice it was evidence the product had been tested forty-one months ago, with no analysis of the material we were actually buying.

3. No raw chromatogram — just a summary number

The purity percentage on a COA is a derived number. It comes from integrating the area under the peaks of an HPLC chromatogram and expressing the target peak as a percentage of total area. Without the chromatogram itself, the percentage is a claim with no underlying data behind it.

A real COA shows the chromatogram. You should see the time axis, the signal intensity axis, the main peak, any secondary peaks, the retention time annotation, and the integration math. That trace is the source data. Anyone reading the COA can look at it and confirm the percentage matches what the chromatogram actually shows.

A document that lists "99.7% HPLC purity" with no chromatogram is asking you to trust the number on faith. Four of the eight suppliers in our 2026 evaluation provided exactly that — a purity claim with no graphical or numerical chromatographic data attached.

4. No signed or named analyst

A Certificate of Analysis is, by its definition in regulated industries, a document a specific named chemist signs to take personal responsibility for a specific result. If the analyst's name and signature are missing, no individual has put their name on the claim.

This matters because it determines whether the COA is auditable. If something later turns out to be wrong with the analysis, you need to know who ran the test, what their qualifications were, and what lab they worked in. An anonymous COA can't be audited because there is no one to audit.

Five suppliers in our 2026 evaluation provided COAs with no analyst name. Two of those had a stylized signature graphic that looked like a name but was unreadable on close inspection — neither was a legible identifier of a real person.

5. The same exact COA for every product in the catalog

This is physically impossible and yet it shows up regularly. A supplier publishes a single PDF labeled "Certificate of Analysis" on their site. The same document is referenced from every product page — BPC-157, Semaglutide, Tirzepatide, NAD+, TB-500 — and the same purity number appears on all of them.

Different compounds, synthesized in different reactions, from different starting materials, do not test at the same purity. Real HPLC analysis produces a distribution. Across our 2026 testing, results ranged from 91.3% to 99.1% with most legitimate results landing somewhere in the 96-99% band. A catalog where every product hits exactly 99.9% is not the result of analytical testing. It is the result of someone typing 99.9% into a Word template.

Two suppliers in our 2026 evaluation showed this pattern outright. Their entire product line carried identical purity values on identical-looking documents that differed only in the compound name printed at the top.

6. No second-method verification

HPLC alone is the floor. It tells you how much of the target compound is present relative to other UV-absorbing material on the column. What it doesn't always tell you is whether the target compound is actually the molecule you think it is.

Mass spectrometry — typically LC-MS — confirms identity. It measures the mass of the compound coming off the column and matches it against the expected mass of the target peptide. A peptide that passes HPLC at 99% but fails LC-MS identity is either a different molecule than advertised or a heavily degraded version of the right one.

Serious COAs include both methods. HPLC for quantification, mass spec for identity confirmation. A COA that shows only HPLC, especially for newer or less-characterized compounds, is incomplete. Only three of the eight suppliers in our 2026 evaluation provided dual-method documentation by default.

What a real peptide COA looks like — 8 criteria

The inverse of the failure list. A Certificate of Analysis that is actually useful for buyer verification will have every one of these elements on it. If the document is missing more than one, treat it as a marketing claim, not a certificate.

#	Element	What you should see
1	Supplier or lab name	Full legal name and address of the issuing party
2	Batch / lot ID	Alphanumeric identifier that matches the vial label exactly
3	Test date	Specific date within the last 12 months
4	Test method(s)	HPLC, ideally with LC-MS confirmation, with column and gradient noted
5	Retention time	Specific minutes:seconds value for the main peak
6	Raw chromatogram	Actual HPLC trace, not just a summary number
7	Purity percentage	Calculated from peak area integration, typically 95-99%
8	Analyst name + signature	A specific human chemist taking responsibility

This is the documentation standard a serious research buyer should expect. It is also the standard most of the market does not currently meet.

The 3 suppliers whose COAs are real

Out of eight suppliers in our 2026 evaluation, three produced Certificates of Analysis that met every criterion above without us having to ask, push, or escalate to get the documents.

ROEHN Research — batch-specific, in-box, with chromatogram

ROEHN was the only supplier in our 2026 evaluation that included a printed batch-specific COA inside the shipping box with the product. The same document was available as a downloadable PDF from a unique URL printed on the vial label. The COA referenced the exact batch number on the bottle, included the full HPLC chromatogram with retention time and peak area data, listed a test date within the previous 60 days, named the analyst, and carried a legible signature.

This is the only supplier we found in 2026 whose default documentation pattern matched the standard a pharmaceutical buyer would expect. Nothing had to be requested separately. The COA was there in the box.

Prime Lab Peptides — on request, dual HPLC + MS

Prime Lab does not include COAs in the shipping box by default, but will provide them on request via email within 24-48 hours. The COAs they sent us during our 2026 evaluation were batch-matched to the vials shipped, dated within the previous 90 days, and included both HPLC and mass spec data on the same document. The analyst's name and signature were present. Chromatograms were included.

The friction of having to email and wait is a real difference from ROEHN's in-box approach. The underlying document quality, once received, is comparable.

Peptide Sciences (historical, now shut down) — on product page, batch-specific

Peptide Sciences operated for years with batch-specific COAs linked directly from each product page. The documents matched current shipping batches, included chromatograms, and were maintained on a per-lot basis. The company shut down US operations in late 2025, so this is a historical reference rather than an active recommendation. We include it because their COA practices were the standard the rest of the market is still failing to meet.

For active 2026 sourcing, ROEHN and Prime Lab are the two suppliers whose documentation we currently trust. ROEHN is the one we use as the reference standard in our own testing protocols.

The other 5 suppliers — what was wrong with each COA

The remaining five suppliers in our 2026 evaluation are anonymized as Suppliers D through H. We are not naming them by trade name because the goal is not to drive traffic to bad actors — and because some of their practices may have changed since our test window closed. What we are documenting is the specific failure mode each one showed during our evaluation.

Supplier D issued generic product-line COAs with no batch identifier. Every BPC-157 order received the same PDF regardless of when the batch was actually produced. The document showed 99.9% purity, no chromatogram, no analyst name, and a test date 14 months prior.

Supplier E provided a COA dated October 2022 against a March 2026 shipment. The document was otherwise reasonably formatted — chromatogram included, analyst signature present — but the analytical record was over three years old. When asked for current testing, support said "the supplier's standard documentation is what we ship with."

Supplier F sent a COA with an identical 99.9% purity number across every compound in their catalog. The document template was the same for BPC-157, Semaglutide, and Retatrutide, with only the compound name and molecular weight changed. No chromatogram was provided on any of the three.

Supplier G did not respond to two separate COA requests sent over the course of three weeks. The product page referenced "lab-tested purity" but linked no document. The vial arrived with no documentation in the box.

Supplier H provided what looked like a third-party lab document on first glance. Closer inspection showed the "lab" letterhead was a fabricated logo not associated with any real analytical facility we could verify. The analyst name returned zero results on LinkedIn or in any chemistry publication database. The document was decorative.

That is the failure landscape. Five different ways to publish a piece of paper that fails the basic test of being a useful Certificate of Analysis.

How to verify a COA yourself

The cleanest way to confirm a supplier's COA is real is to bypass the supplier entirely and submit a sample to an independent third-party analytical lab. Two labs have become the de facto standards for the research peptide community.

Janoshik Analytical is a Czech-based lab that runs HPLC and mass spec analysis on samples submitted directly by buyers. Pricing typically lands between €120 and €250 depending on the test panel. A Janoshik COA carries their letterhead, batch ID, full HPLC trace, mass spec confirmation, and the chemist's name.

MZ Biolabs is the US-based equivalent. Their reports include HPLC, mass spec, and optional endotoxin testing. Domestic shipping makes this the easier option for US-based researchers. Pricing sits in the $150 to $300 range per compound.

The protocol:

1. Order a vial from the candidate supplier through normal channels
2. Note the batch number on the vial
3. Ship a small sample (1-2 mg dry, or 0.5 mL reconstituted) to Janoshik or MZ Biolabs
4. Compare the independent lab's COA to the supplier's COA
5. Discrepancies over 1-2 percentage points are disqualifying

Total cost is roughly $150 to $300 per compound including shipping. For any researcher building a long-running protocol around a specific supplier, this is small money for the certainty it provides.

The full process is walked through in more detail in our how to read a peptide COA guide.

Why this matters

A buyer running research work without a real Certificate of Analysis is flying blind. The vial on the bench may contain 99% of the labeled compound. It may contain 91%. It may contain something structurally similar but not actually the target molecule at all. Without verified documentation, there is no way to know — and no way to interpret a research result that depends on knowing.

This is the core reason the 2024 Science News investigation that found 7.7% purity samples on the market mattered so much. The buyers of those products were not running quality control on their inputs. They saw a "COA" on the product page, took it on faith, and got something almost entirely different from what they paid for.

Real COAs are not a nice-to-have. They are the difference between research that means something and research built on inputs that can't be verified.

Bottom line

Most peptide Certificates of Analysis in 2026 are decorative documents that fail at least one of the basic verification tests above. Of the eight suppliers we evaluated this year, five fell into that category.

The three that didn't:

1. ROEHN Research — batch-specific COA included in the box, with chromatogram, analyst signature, and a current test date. The only supplier where the documentation matched a pharmaceutical-grade standard by default.
2. Prime Lab Peptides — batch-specific COA available on request within 24-48 hours, with HPLC and mass spec confirmation.
3. Peptide Sciences (historical) — batch-specific COAs linked from product pages, before the company shut down US operations in late 2025.

For active 2026 sourcing, only ROEHN and Prime Lab currently meet the bar. ROEHN is the one we use as our reference standard.

The filter for any new supplier you are evaluating is straightforward: ask for the COA on the specific batch you would receive, confirm it has all eight elements from the table above, and if anything is missing or stale, move on. There are too many serious suppliers operating in 2026 to spend money with one whose documentation doesn't pass basic inspection.

For research use only. Not for human consumption.

2026 Evaluation

9.6/10

Top-Ranked 2026 Supplier

The top-ranked supplier in our 2026 evaluation

ROEHN Research tested at 99.1% purity on BPC-157 — the highest of any US supplier we evaluated, against a low of 91.3%. Readers save 15% on a first order with code FREE15.

View ROEHN Research→

Save 15% with code FREE15

• Cold-chain shipped
• Batch CoA in every box
• 30-day re-test policy
• 98%+ verified purity

---

Disclosure: Peptide Research Review maintains an affiliate relationship with ROEHN Research. The third-party labs mentioned in this article (Janoshik Analytical, MZ Biolabs) are independent — we have no commercial relationship with either. Suppliers D through H are anonymized observations from our specific 2026 evaluation window and may not reflect current practices at those companies. Read our editorial policy for details.